Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra proof-of-concept study in anaplastic thyroid cancer
NL-OMON46644Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of anakinra in anaplastic thyroid cancer (ATC), sponsored by Radboud University Medical Center. Primary endpoints: Health-related quality of life, Tumor progression and 1 more. Started Oct 2018; status: active, not recruiting.
02
Drugs
anakinra
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NL-OMON46644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46644.